Free Trial

TerrAscend Corp. (OTCMKTS:TSNDF) Short Interest Update

TerrAscend logo with Medical background
Remove Ads

TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,621,900 shares, an increase of 53.8% from the February 28th total of 1,704,200 shares. Approximately 1.3% of the shares of the stock are short sold. Based on an average daily volume of 1,976,300 shares, the short-interest ratio is presently 1.3 days.

TerrAscend Price Performance

Shares of TSNDF traded down $0.01 during midday trading on Monday, reaching $0.48. The stock had a trading volume of 159,423 shares, compared to its average volume of 430,273. The company has a market capitalization of $140.40 million, a price-to-earnings ratio of -1.71 and a beta of 1.64. The company has a current ratio of 1.35, a quick ratio of 0.69 and a debt-to-equity ratio of 0.81. TerrAscend has a 12-month low of $0.38 and a 12-month high of $2.20. The company's 50-day moving average is $0.52 and its 200 day moving average is $0.77.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The company reported $0.01 EPS for the quarter, beating analysts' consensus estimates of ($0.03) by $0.04. The business had revenue of $74.35 million for the quarter, compared to analysts' expectations of $72.37 million. TerrAscend had a negative net margin of 23.95% and a negative return on equity of 31.48%. On average, equities analysts predict that TerrAscend will post -0.14 EPS for the current fiscal year.

Remove Ads

Wall Street Analysts Forecast Growth

Separately, Atb Cap Markets lowered shares of TerrAscend from a "strong-buy" rating to a "hold" rating in a report on Monday, December 9th.

Check Out Our Latest Research Report on TSNDF

About TerrAscend

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.

Featured Stories

Should You Invest $1,000 in TerrAscend Right Now?

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads